Table 2 Demographic and disease characteristics of study participants
Variable | Discontinuation (n = 148) | Continuation (n = 146) | p value | ||
|---|---|---|---|---|---|
Gender: male | Cases (%) | 114 (77) | 102 (70) | 0.1642 | |
Age (yr) | Mean ± SD | 54.4 ± 10.1 | 54.6 ± 9.5 | 0.8873 | |
Body mass index (%) | Mean ± SD | 26.3 ± 5.6 | 26.8 ± 5.8 | 0.4633 | |
Diabetes duration (yr) | Mean ± SD | 12.2 ± 7.8 | 11.5 ± 7.8 | 0.4543 | |
Discontinuation duration (yr) | Mean ± SD | 2.6 ± 2.4 | — | — | |
Discontinuation ratio (%) | Mean ± SD | 23.1 ± 22.0 | — | — | |
Age at resumption (yr) | Mean ± SD | 50.9 ± 9.6 | — | — | |
Complications | Cases (%) | 22 (15) | 15 (10) | 0.2352 | |
Number of medications1 | Mean ± SD | 4.2 ± 3.4 | 4.3 ± 3.9 | 0.7913 | |
Insulin use | Cases (%) | 24 (16) | 21 (14) | 0.6082 | |
Hypoglycaemia (episodes per year) | Cases (%) | 27 (18) | 30 (21) | 0.6172 | |
Drug-related side effects | Cases (%) | 34 (23) | 34 (23) | 0.9492 | |
Familial history of diabetes | Cases (%) | 75 (51) | 62 (43) | 0.1582 | |
Current smoking habit | Cases (%) | 27 (18) | 31 (21) | 0.5202 | |
HbA1c (%) (mmol/mol) | Mean ± SD | 7.4 ± 1.4 58.3 ± 16.4 | 7.2 ± 1.1 55.1 ± 11.7 | 0.1313 | |
HbA1c under control | Cases (%) | 79 (53) | 78 (53) | 0.9942 | |
MMAS-8 adherence classification | High (8) | Cases (%) | 30 (20) | 51 (35) | 0.0172 |
Medium (≥ 6 and < 8) | Cases (%) | 57 (39) | 43 (30) | ||
Low (< 6) | Cases (%) | 61 (41) | 52 (36) | ||